This article has been updated to include comments from a conference call and a stock quote.
 
NEW YORK (GenomeWeb News) – Cepheid reported today that its fourth-quarter revenues rose 71 percent, driven by increasing adoption of its GeneXpert system among hospitals outside of the Veterans Administration system, as the firm cut its net loss 36 percent year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.